GlassScriptPhysician profile
Ramon D Garcia
NPI 1750344925
$4,343.78
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,514 · 2020: $1,179 · 2021: $1,445 · 2022: $205.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $491.38 | 2019-2021 | |
| Esperion Therapeutics, INC. | $458.87 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $457.09 | 2019-2020 | |
| Novo Nordisk INC | $416.97 | 2019-2022 | |
| Amgen INC. | $410.66 | 2019-2022 | |
| Abbvie INC. | $270.78 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.42 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $201.14 | 2019-2021 | |
| Eisai INC. | $165.83 | 2019-2021 | |
| Genentech USA, INC. | $147.23 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $139.29 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $132.36 | 2019-2021 | |
| Lilly USA, LLC | $122.42 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.83 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $72.77 | 2019-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $69.57 | 2019-2021 | |
| Amarin Pharma, INC. | $43.01 | 2019-2020 | |
| Gilead Sciences, INC. | $41.52 | 2019 | |
| Horizon Therapeutics Plc | $40.23 | 2020 | |
| Optinose US, INC. | $38.58 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.76 | 2019 | |
| Allergan, INC. | $33.22 | 2020 | |
| Novartis Pharmaceuticals Corporation | $32.49 | 2019 | |
| Mission Pharmacal Company | $29.80 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $25.71 | 2021 | |
| Arbor Pharmaceuticals, INC. | $23.73 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.37 | 2022 | |
| Ironshore Pharmaceuticals INC. | $17.85 | 2020 | |
| Abbott Laboratories | $16.69 | 2021 | |
| Glaxosmithkline, LLC. | $16.30 | 2019 | |
| Heartflow, INC. | $14.33 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.83 | 2021 | |
| Scilex Pharmaceuticals INC. | $12.75 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.